Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $1.93 in the prior trading day, Taysha Gene Therapies Inc (NASDAQ: TSHA) closed at $1.39, down -27.98%. In other words, the price has decreased by -$27.98 from its previous closing price. On the day, 12.46 million shares were traded. TSHA stock price reached its highest trading level at $1.7498 during the session, while it also had its lowest trading level at $1.17.
Ratios:
Our goal is to gain a better understanding of TSHA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 398519936 and an Enterprise Value of 209475264. For the stock, the TTM Price-to-Sale (P/S) ratio is 34.21 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 25.138 whereas that against EBITDA is -2.454.
Stock Price History:
The Beta on a monthly basis for TSHA is 0.73, which has changed by -0.48708487 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is -15.73%, while the 200-Day Moving Average is calculated to be -32.17%.
Shares Statistics:
The stock has traded on average 1.96M shares per day over the past 3-months and 2936530 shares per day over the last 10 days, according to various share statistics. A total of 204.94M shares are outstanding, with a floating share count of 165.01M. Insiders hold about 19.51% of the company’s shares, while institutions hold 77.27% stake in the company. Shares short for TSHA as of 1741910400 were 25248849 with a Short Ratio of 12.89, compared to 1739491200 on 25087077. Therefore, it implies a Short% of Shares Outstanding of 25248849 and a Short% of Float of 16.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
